Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-small Cell Lung Cancer (NSCLC) · Colorectal Cancer (CRC) · Pancreatic Adenocarcinoma · Pancreatic Ductal Adenocarcinoma (PDAC) · PDAC · CRC · NSCLC · Pancreatic Cancer · Lung Cancer (NSCLC) · Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

START Midwest, Grand Rapids, Michigan, United States
Contact: Study coordinator (Olivia Sweeney) · olivia.sweeney@startresearch.com · 616-954-6674
NEXT - Dallas, Dallas, Texas, United States
Contact: Study coordinator (NEXT TXReferrels) · NXT_TXReferrals@nextoncology.com · 972-893-8800
NEXT, San Antonio, Texas, United States
Contact: Study coordinator (Jordan Georg) · jgeorg@nextoncology.com · 210-580-9521
START - San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Isabel Jimenez) · isabel.jimenez@startresearch.com · 210-593-5265
NEXT - Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (Paolo Umayam) · pumayam@nextoncology.com · 703-783-4546

View source on ClinicalTrials.gov Contact study team (email)